Mirador Capital Partners LP Has $1.59 Million Stake in Cardinal Health, Inc. (NYSE:CAH)

Mirador Capital Partners LP grew its holdings in Cardinal Health, Inc. (NYSE:CAH) by 3.6% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 13,429 shares of the company’s stock after purchasing an additional 466 shares during the period. Mirador Capital Partners LP’s holdings in Cardinal Health were worth $1,588,000 as of its most recent SEC filing.

A number of other large investors also recently made changes to their positions in CAH. Eastern Bank acquired a new position in shares of Cardinal Health in the 3rd quarter valued at about $25,000. Frazier Financial Advisors LLC increased its holdings in shares of Cardinal Health by 69.8% in the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock valued at $28,000 after purchasing an additional 104 shares during the period. Hara Capital LLC acquired a new position in shares of Cardinal Health in the 3rd quarter valued at about $31,000. AM Squared Ltd acquired a new position in shares of Cardinal Health in the 3rd quarter valued at about $33,000. Finally, Carolina Wealth Advisors LLC acquired a new position in shares of Cardinal Health in the 3rd quarter valued at about $47,000. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Trading Down 0.0 %

CAH opened at $124.67 on Thursday. Cardinal Health, Inc. has a 1-year low of $93.17 and a 1-year high of $126.23. The stock has a market capitalization of $30.17 billion, a price-to-earnings ratio of 24.25, a P/E/G ratio of 1.48 and a beta of 0.63. The business has a 50 day moving average of $120.46 and a 200-day moving average of $111.50.

Cardinal Health (NYSE:CAH) last issued its earnings results on Friday, November 1st. The company reported $1.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26. Cardinal Health had a negative return on equity of 56.56% and a net margin of 0.56%. The firm had revenue of $52.28 billion for the quarter, compared to analysts’ expectations of $50.90 billion. During the same quarter last year, the business earned $1.73 earnings per share. The company’s revenue was down 4.3% compared to the same quarter last year. Equities analysts predict that Cardinal Health, Inc. will post 7.82 EPS for the current year.

Cardinal Health Cuts Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd were issued a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a dividend yield of 1.62%. The ex-dividend date was Thursday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is presently 39.30%.

Wall Street Analyst Weigh In

A number of research firms recently commented on CAH. Evercore ISI upgraded Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price objective on the stock in a report on Tuesday, January 7th. Morgan Stanley increased their price objective on Cardinal Health from $127.00 to $136.00 and gave the stock an “overweight” rating in a report on Tuesday, December 17th. Citigroup increased their price objective on Cardinal Health from $120.00 to $129.00 and gave the stock a “neutral” rating in a report on Friday, January 10th. TD Cowen upgraded Cardinal Health from a “hold” rating to a “buy” rating and increased their price objective for the stock from $130.00 to $144.00 in a report on Wednesday, January 8th. Finally, UBS Group increased their price objective on Cardinal Health from $134.00 to $139.00 and gave the stock a “buy” rating in a report on Monday, November 4th. Four research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $133.29.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.